CN Patent

CN1076614A — 脂质体依太康唑制剂

Assigned to Janssen Cilag SpA · Expires 1993-09-29 · 33y expired

What this patent protects

本发明涉及包含依太康唑、磷脂、供依太康唑和所述磷脂用的溶剂体系、水和常规的辅助配制剂的局部用脂质体制剂，及所述制剂的制备方法。

USPTO Abstract

本发明涉及包含依太康唑、磷脂、供依太康唑和所述磷脂用的溶剂体系、水和常规的辅助配制剂的局部用脂质体制剂，及所述制剂的制备方法。

Drugs covered by this patent

Jublia (EFINACONAZOLE) · Bausch Health

Patent Metadata

Patent number: CN1076614A
Jurisdiction: CN
Classification: —
Expires: 1993-09-29
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Cilag SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.